The 5th Annual Targeted Protein Degredation (TPD) Europe covers topics such as:
- From Serendipity to Late Stage Clinical Development: New Update Towards First-In-Class Approval
- Discovery & Early-Stage Development
- Novel Platforms & Screening for High Throughput Targets & E3 Hit Finding for PROTACs
- Preclinical, Translational & Clinical Considerations
- Leveraging Robust Lead Optimisation to Enable Efficacious Translation for PROTACs
- Broadening the Horizon of TPD From Oncology via Alternative Pathways
- Lessons Learned From the Clinic to Bolster Translation of Next Wave of Novel Degraders
- Harnessing Best-in-Class Modeling Systems, Unique Modes of Action, & Tissue-Sparing Ligases to Address Selectivity, Safety, & Efficacy Over Inhibition
- Unravelling Induced Proximity’s Potential to Degrade
The 5th Annual Targeted Protein Degredation (TPD) Europe might be held in London, United Kingdom in Mar 2025.
